Preferred Name |
Brexpiprazole |
|
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/NCIT_C166575 |
|
Accepted_Therapeutic_Use_For |
Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults. Treatment of schizophrenia in adults and pediatric patients ages 13 years and older. |
|
CAS_Registry |
913611-97-9 |
|
code |
C166575 |
|
Contributing_Source |
FDA |
|
FDA_UNII_Code |
2J3YBM1K8C |
|
in_subset | ||
label |
Brexpiprazole |
|
Preferred_Name |
Brexpiprazole |
|
prefixIRI |
NCIT:C166575 |
|
prefLabel |
Brexpiprazole |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C3885614 |
|
subClassOf |
Create mapping